EGTX

STO · Equity

Egetis Therapeutics AB (publ)

SE Healthcare Biotechnology

Latest week
29 May 2026
Close
6.080000
Fair value
5.324103
Expectation
Negative 41.94%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
6.08
12-Week Change
16.25%
Trend Signal
Active
Expectation
Negative 41.94%
Signal Weeks
3 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.22
Market Dynamics
1.14

Over the latest 12 completed weeks ending 2026-05-29, EGTX rose 16.25%, moving from 5.23 to 6.08. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 2.22 and has improved across the 12-week window. Market Dynamics is 1.14 on the latest week. Expectation is negative at 41.94%.